The molecular mechanism of FSHD is complex and involves both genetic and epigenetic components leading to the activation in skeletal muscle of DUX4, a gene normally mostly expressed in germline and early embryogenesis (reviewed in [18]). The gene discussed is DUX4; the disease is Facioscapulohumeral dystrophy.